SINI, MARIA CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 2.698
NA - Nord America 1.307
EU - Europa 782
SA - Sud America 443
AF - Africa 40
OC - Oceania 3
Totale 5.273
Nazione #
US - Stati Uniti d'America 1.232
SG - Singapore 1.062
CN - Cina 574
BR - Brasile 367
IT - Italia 316
HK - Hong Kong 303
VN - Vietnam 252
FR - Francia 134
JP - Giappone 134
BD - Bangladesh 129
NL - Olanda 103
KR - Corea 81
DE - Germania 58
IN - India 48
GB - Regno Unito 39
CA - Canada 38
FI - Finlandia 25
AR - Argentina 21
ID - Indonesia 18
IL - Israele 17
ZA - Sudafrica 16
MX - Messico 15
AT - Austria 14
IE - Irlanda 14
IQ - Iraq 14
EC - Ecuador 13
CO - Colombia 11
PL - Polonia 10
VE - Venezuela 10
RU - Federazione Russa 9
KE - Kenya 8
SA - Arabia Saudita 8
TR - Turchia 8
UY - Uruguay 8
CZ - Repubblica Ceca 7
PK - Pakistan 7
ES - Italia 6
MA - Marocco 6
PY - Paraguay 6
UA - Ucraina 6
JM - Giamaica 5
LT - Lituania 5
PH - Filippine 5
CH - Svizzera 4
HN - Honduras 4
KZ - Kazakistan 4
PE - Perù 4
UZ - Uzbekistan 4
AL - Albania 3
CR - Costa Rica 3
DZ - Algeria 3
HU - Ungheria 3
MY - Malesia 3
NO - Norvegia 3
SE - Svezia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CU - Cuba 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 5.270
Città #
Singapore 608
Santa Clara 305
Hong Kong 300
Hefei 188
San Jose 146
Tokyo 119
Ashburn 118
Lauterbourg 112
Beijing 106
Ho Chi Minh City 96
Seoul 78
Los Angeles 68
Hanoi 66
Dallas 56
São Paulo 37
New York 33
Cavallino 29
Genoa 24
Milan 22
Council Bluffs 19
Cagliari 18
Rome 16
Buffalo 14
Dublin 14
Helsinki 14
Amsterdam 13
Frankfurt am Main 13
Rio de Janeiro 13
Minamishinagawa 12
Orem 12
Phoenix 12
Boardman 11
Guangzhou 11
Naples 11
Florence 10
Montreal 10
Nuremberg 10
Porto Alegre 10
Curitiba 9
Düsseldorf 9
Johannesburg 9
Vienna 9
Boston 8
Brooklyn 8
Manchester 8
Nairobi 8
Sala Baganza 8
Toronto 8
Bengaluru 7
Chennai 7
Hải Dương 7
Jakarta 7
Montevideo 7
Mumbai 7
Salvador 7
Turku 7
Belo Horizonte 6
Chicago 6
Houston 6
Las Vegas 6
London 6
Munich 6
Bari 5
Bắc Giang 5
Da Nang 5
Denver 5
Duque de Caxias 5
Goiânia 5
Philadelphia 5
Quảng Ninh 5
Riyadh 5
San Francisco 5
Sassari 5
Seattle 5
Shanghai 5
Baghdad 4
Betim 4
Bologna 4
Calgary 4
Casablanca 4
Dhaka 4
Haiphong 4
Hortolândia 4
Jacksonville 4
Kingston 4
Lappeenranta 4
Loerrach 4
Ludwigsburg 4
Maceió 4
Poplar 4
Prague 4
Quận Một 4
Recife 4
San Gregorio di Catania 4
Santa Maria 4
St Louis 4
Tashkent 4
Tel Aviv 4
The Bronx 4
Thái Nguyên 4
Totale 3.095
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 121
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 87
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 81
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 79
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 77
Il CSCC: aspetti distintivi della patologia 77
Germline and somatic NGS-based analysis on BRCA-related tumors 76
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 74
Idiopathic pulmonary fibrosis (IPF) and lung cancer 72
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis 71
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 69
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 69
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 68
Genetic alterations in main candidate genes during melanoma progression. 67
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 66
nalysis of Fanconi anemia genes in colorectal cancer. 66
Liquid biopsy in clinical oncology 66
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 65
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 64
Epidemiology and Genetic Susceptibility of Breast and Ovarian Cancer in Sardinian Population 62
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 62
Molecular landscape profile of melanoma 62
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 61
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
Genetic Instability Markers in Cancer 60
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 57
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 54
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 54
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 52
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 52
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 52
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 51
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 51
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 50
Ngs-based analysis of atypical deep penetrating nevi 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 49
Genetic alterations at chromosome 9p21 and melanoma progression. 47
Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing 47
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 46
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 44
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 43
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 42
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy 41
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 41
Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases 41
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 40
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 39
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 39
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. 38
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 37
Analyses of key-regulator genes in melanoma susceptibility and pathogenesis among patients from south Italy. 35
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 35
Molecular analysis of Fanconi anemia (FA) and mismatch repair (MMR) genes in patients with colorectal carcinoma 35
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 35
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 34
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 34
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 34
Long non-coding RNA CASC2 in human cancer 34
Molecular classification for the management of melanoma patients. 32
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 32
Immunoreactivity for Ca 125 and INI 1 loss of expression are useful markers in the diagnosis of vulvar proximal-type epithelioid sarcomas: Report of two cases 32
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
NEMO-binding domain peptide inhibits proliferation of human melanoma cells. 32
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 32
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy 31
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 31
NEMO-binding domain peptide inhibits proliferation of human melanoma cells. 30
Overexpression of h-prune in breast cancer is correlated with advanced disease status 30
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 30
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 30
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 30
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma 30
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 30
Genetic alterations in main candidate genes during melanoma progression 30
Fanconi genes may contribute to melanoma pathogenesis. 29
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 29
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 29
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 29
Liquid biopsy in prostate cancer: A multidisciplinary expert consensus statement 28
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 27
Epidemiological and genetic factors underlying melanoma development in Italy 27
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia. 27
Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. 27
CORRELATION BETWEEN ARGINOSUCCINATE SYNTHETASE (ASS) EXPRESSION AND TREATMENT WITH ARGININE DEIMINASE (ADI) IN MELANOMA CELL LINES. 27
Expression of arginino-succinate synthetase (ASS) and response to arginine deiminase (ADI) treatment in a series of melanoma cell lines. AACR-NCI-EORTC 26
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 26
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 26
Discrepant alterations in main candidate genes among multiple primary melanomas 26
The EGF 61A>G polymorphism has no role in nevi formation and melanoma pathogenesis within italian population 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis 25
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 25
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: Report of two cases with molecular analysis 25
Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients 25
Downregulation of the CASC2a gene in endometrial cancer. 25
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 25
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 25
Totale 4.487
Categoria #
all - tutte 18.475
article - articoli 14.160
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 778
Totale 33.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202421 0 0 0 0 0 0 0 0 4 0 13 4
2024/20251.829 17 8 109 71 310 83 37 102 68 123 465 436
2025/20263.446 153 264 303 397 522 139 550 274 236 241 173 194
2026/2027120 120 0 0 0 0 0 0 0 0 0 0 0
Totale 5.416